Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region

Saturday, May 20, 2023

Thermo Fisher Scientific the world leader in serving science has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines in the AsiaPacific market The new facility also marks a significa...

Bruker Introduces Next-Generation Automated BioAFM for Quantification of Molecular Forces

Wednesday, May 31, 2023

Bruker has announced the release of the ForceRobot BioAFM which marks a new milestone in force measurement capabilities It sets new standards in automation generating over force curves per day to deliver the statistically significant datasets requi...

BioLight announces a joint cooperation agreement with Alexion (AstraZeneca Rare Disease) to explore an innovative technology based on natural tears for the diagnosis of retinal diseases

Wednesday, May 31, 2023

BioLight TASE BOLT is proud to report it has signed a research collaboration agreement with Alexion AstraZeneca Rare Disease focusing on exploring a groundbreaking technology that utilizes natural tears for the potential diagnosis of retinal diseases

Seagen Stockholders Approve Acquisition by Pfizer

Wednesday, May 31, 2023

Following a special meeting of its stockholdersSeagen Inc Nasdaq SGEN today announced that its stockholders voted to approve a proposal to adopt the previously announced merger agreement under which Pfizer will acquire Seagen for per share in cash M...

An Innovative Drug, ILUMETRI ‘Tildrakizumab Injection’ Approved for Marketing in China

Wednesday, May 31, 2023

On May China Medical System Holdings Limited CMS or the Group announced that on May the New Drug Application NDA of Tildrakizumab Injection under the brand name of ILUMETRI has been approved by the National Medical Products Administration of China...

ONO Submits Supplemental Applications for Approval of BRAFTOVI® Capsule and MEKTOVI® Tablet in Japan for the Treatment of Radically Unresectable BRAF-Mutant Thyroid Cancer

Wednesday, May 31, 2023

Ono Pharmaceutical Co Ltd Osaka Japan President and CEO Gyo Sagara ONO today announced that it has submitted supplemental applications for approval of BRAFTOVI generic name encorafenib Capsule BRAFTOVI a BRAF inhibitor and MEKTOVI generic name binime...

New Investment of Over 50 Billion Yen in Bio Manufacturing Facilities to Strengthen the Production Base to Support the Rapid Launch of In-House Projects

Wednesday, May 31, 2023

Chugai Pharmaceutical Co Ltd TOKYO announced its decision today to construct a new bio active pharmaceutical ingredients APIs manufacturing building and injection building in the Utsunomiya Plant Utsunomiya City Tochigi Prefecture of Chugai Pharma M...

Xcode Life forays into Nutrigenomics launching a comprehensive Gene Nutrition test

Friday, May 26, 2023

Xcode Life one of Indias leading personal genomics companies has now forayed into Nutrigenomics The company has launched Indias most comprehensive Gene Nutrition test covering nearly aspects of nutrition The test looks into macro carbs protein and f...

Shanghai Pharmaceutical Pyridostigmine Bromide Sustained Release Tablets Approved for Clinical Trials

Sunday, May 28, 2023

Recently the Pyridostigmine Bromide Sustainedrelease Tablets developed by Shanghai Shanghai Pharmaceutical Zhongxi Pharmaceutical Co Ltd a subsidiary of Shanghai Pharmaceuticals received the Notice of Drug Clinical Trial Approval issued by the State...

AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

Monday, May 29, 2023

Amplia has today released new preclinical data showing the efficacy of its highly selective FAK inhibitor AMP in an animal model of pancreatic cancer when used in combination with FOLFIRINOX treatment